STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.

Rozovski, Uri; Veletic, Ivo; Harris, David M; Li, Ping; Liu, Zhiming; Jain, Preetesh; Manshouri, Taghi; Ferrajoli, Alessandra; Burger, Jan A; Bose, Prithviraj; Thompson, Phillip A; Jain, Nitin; Wierda, William G; Verstovsek, Srdan; Keating, Michael J; Estrov, Zeev

Rozovski, Uri; Veletic, Ivo; Harris, David M; Li, Ping; Liu, Zhiming; Jain, Preetesh; Manshouri, Taghi; Ferrajoli, Alessandra; Burger, Jan A; Bose, Prithviraj; Thompson, Phillip A; Jain, Nitin; Wierda, William G; Verstovsek, Srdan; Keating, Michael J; Estrov, Zeev.

Afiliação

Rozovski U; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Veletic I; Division of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel; and.
Harris DM; The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Li P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Liu Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Jain P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Manshouri T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Burger JA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Thompson PA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

J Immunol ; 208(12): 2847-2855, 2022 06 15.

Article em En | MEDLINE | ID: mdl-35595309

Assuntos

Proteína C-Reativa; Leucemia Linfocítica Crônica de Células B; Fator de Transcrição STAT3; Componente Amiloide P Sérico; Proteína C-Reativa/genética; Proteína C-Reativa/metabolismo; Células Endoteliais/metabolismo; Humanos; Fator de Transcrição STAT3/genética; Fator de Transcrição STAT3/metabolismo; Componente Amiloide P Sérico/genética; Componente Amiloide P Sérico/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Componente Amiloide P Sérico / Leucemia Linfocítica Crônica de Células B / Fator de Transcrição STAT3 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google